GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors
Clinical trial NCT03693612 · COMPLETED
Trial details
- NCT number
- NCT03693612
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2021-06-25
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.